Target
Uracil-DNA glycosylase
Ligand
BDBM294508
Substrate
n/a
Meas. Tech.
Processive DNA synthesis assay
pH
7.5±n/a
EC50
10000±n/a nM
Comments
extracted
Citation
 Ricciardi, RPReitz, ABParker, MHBaugh, SDNuth, MGuan, H Antivirals against molluscum contagiosum virus US Patent  US10112895 Publication Date 10/30/2018 
Target
Name:
Uracil-DNA glycosylase
Synonyms:
OPG116 | UDG | UNG | UNG_VACCW
Type:
PROTEIN
Mol. Mass.:
25071.48
Organism:
Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR))
Description:
ChEMBL_747132
Residue:
218
Sequence:
MNSVTVSHAPYTITYHDDWEPVMSQLVEFYNEVASWLLRDETSPIPDKFFIQLKQPLRNKRVCVCGIDPYPKDGTGVPFESPNFTKKSIKEIASSISRLTGVIDYKGYNLNIIDGVIPWNYYLSCKLGETKSHAIYWDKISKLLLQHITKHVSVLYCLGKTDYSNIRAKLESPVTTIVGYHPAARDRQFEKDRSFEIINVLLELDNKAPINWAQGFIY
  
Inhibitor
Name:
BDBM294508
Synonyms:
5-[(2- benzyloxyphenyl)methylamino]- 1,3-dihydrobenzimidazol-2-one | US10112895, Compound 2
Type:
Small organic molecule
Emp. Form.:
C21H19N3O2
Mol. Mass.:
345.3945
SMILES:
O=c1[nH]c2ccc(NCc3ccccc3OCc3ccccc3)cc2[nH]1
Structure:
Search PDB for entries with ligand similarity: